Umbilical cord blood processor

Intravenous products: The FDA has given clearance to PrepaCyte-CB umbilical cord blood processing system from BioE Inc. out of St. Paul, Minnesota. The device, already approved in the EU, filters blood for progenitor stem cells, total nucleated cells, and mononucleated cells for a possible use in therapeutic applications.

Click here for the full story on medgadget.

Click here for the press release.

More IV news at IVTEAM

Other stories

• Phenergan claim
• Antimicrobial central venous catheter
• INS conference advanced registration
• Syringe disconnection alert
• Parenteral nutrition and iodine
• Sharp injury in OR
• Home IV therapy
• Intravenous litigation
• IV particles lead to drug recall
• Neonatal infusion
• Syringe pen
• Hand washing and hand gel

Add IVTEAM to Technorati Favorites